Introduction to Platify (Eltrombopag) Tablets
Platify, manufactured by Intas Pharmaceuticals Ltd., contains the active ingredient Eltrombopag and is available in a strength of 25mg. It is formulated as tablets for oral administration and is prescribed for the treatment of Hepatitis C.
Uses of Platify
Platify is specifically indicated for the treatment of Hepatitis C, providing targeted therapeutic support to manage this viral infection effectively.
Benefits of Platify
This medication offers the benefit of potentially improving platelet counts and supporting liver function in patients undergoing treatment for Hepatitis C.
Mechanism of Action of Platify
Platify works by stimulating the production of platelets in the bone marrow and thereby assisting in the management of thrombocytopenia associated with Hepatitis C treatment. It helps restore platelet levels and supports overall liver health during therapy.